JESSICA SCHNEBLY: Open Payments
NPI 1194379412 · LINCOLN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 21 payments from 9 companies in 2025. Trend: 2023 $185 · 2024 $367 · 2025 $669
Food & beverage: $580Education: $89
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 4 | $262 |
| ABBVIE INC. | 9 | $194 |
| Janssen Biotech, Inc. | 2 | $106 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| PFIZER INC. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
Products named: REZDIFFRA, SKYRIZI, TREMFYA, DUPIXENT, IQIRVO, XIFAXAN, VELSIPITY, ENTYVIO.
Industry payments across IL — which companies pay providers there.
